Speaker illustration

Doctor Jonathan Tjerkaski

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes

Thumbnail

This platform is supported by

logo Novo Nordisk